Trial Profile
Phase 1b Study of C1-esterase Inhibitor (Cinryze) With Standard of Care for Acute Treatment of Neuromyelitis Optica Exacerbations
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Neuromyelitis optica; Optic neuritis
- Focus Adverse reactions
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 25 Nov 2013 New trial record